INDICAID COVID-19 Rapid Antigen Test, FDA Emergency Use Authorization
Brand:INDICAID
$3.12
This product has a minimum order quantity of 1 case or 18 kits
Article Number: 2110400
Package Size: 25
Test Name: Covid-19
- Description
- Additional information
Description
A Reliable Indicator for COVID-19 Detection for Professional Use
- FDA EUA: 210259
- For In Vitro Diagnostic Use Only
- Professional Use Only
- CLIA Number Required For Purchase
About
The INDICAID (Professional) COVID-19 Rapid Antigen Test (FDA EUA) is a lateral flow immunoassay designed for the qualitative detection of SARS-CoV-2 antigens in direct nasal swab samples.
Features
- Quick: With INDICAID, users can expect quick results in just 20 minutes.
- Easy: User-friendly testing. No additional equipment or training is required.
- Simple Sampling: INDICAID comes with intuitive vials to obtain self-collected shallow nasal samples.
- Bulk-Testing: Our rapid COVID-19 test allows for the aggregate collection of multiple specimens followed by batch-testing of individual samples up to two (2) hours after collection.
- Detects COVID-19 subvariants: To date, in-house analytical studies have not identified any variants of concern that have an impact to the performance of INDICAID, including Omicron sub-variants BA.4, BA.5, BQ.1, BQ.1.1, XBB.1.5, and XBB.1.16.
Specifications
| Product Code | EUA 210259 |
|---|---|
| Items Per Box | 25 |
| Specimen Type | Direct Anterior Nasal Swab |
| Storage Condition | 36º-86ºF (2º-30ºC) Do not freeze. Avoid direct sunlight. |
| Shelf Life | 15 Months (With 3 Month FDA Extension – Learn More) |
| Accuracy | Sensitivity 88.9%; Specificity 96.8%; Overall accuracy 95.6% |
Additional Information
| Weight | 4 lbs |
|---|---|
| Dimensions | 12 × 12 × 12 in |
